ANEBULO PHARMACEUTICALS, INC. Grants Receivable
ANEBULO PHARMACEUTICALS, INC. (ANEB) had Grants Receivable of $30.76 thousand as of 2024-12-31, per its 10-Q filed 2025-02-14.
Financial Statements › Notes
us-gaap:GrantsReceivable · last filed 2025-02-14
- 2024-12-31: Grants Receivable $30.76K.
- 2024-09-30: Grants Receivable $245.36K.
| Period end | Grants Receivable |
|---|---|
| 2024-12-31 | $30.76K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $245.36K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |